The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Design, Synthesis, and Biological Activity of a Potent Inhibitor of the Neuropeptidase N-Acetylated α-Linked Acidic Dipeptidase
Open accessAbstract
A series of substituted phosphonate derivatives were designed and synthesized in order to study the ability of these compounds to inhibit the neuropeptidase N-acetylated alpha-linked acidic dipeptidase (NAALADase). The molecules were shown to act as inhibitors of the enzyme, with the most potent (compound 3) having a Ki of 0.275 nM. The potency of this compound is more than 1000 times greater than that of previously reported inhibitors of the enzyme. NAALADase is responsible for the catabolism of the abundant neuropeptide N-acetyl-aspartylglutamate (NAAG) into N-acetylaspartate and glutamate. NAAG has been proposed to be a neurotransmitter at a subpopulation of glutamate receptors; alternatively, NAAG has been suggested to act as a storage form of synaptic glutamate. As a result, inhibition of NAALADase may show utility as a therapeutic intervention in diseases in which altered levels of glutamate are thought to be involved.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Microdialysis—Theory and application
Benveniste, H., & Hüttemeier, P. C. (1990) · Progress in Neurobiology · doi:10.1016/0301-0082(90)90027-e · Cited by 646
Abnormal excitatory amino acid metabolism in amyotrophic lateral sclerosis
Rothstein, J. D., Tsai, G., Kuncl, R. W., Clawson, L., Cornblath, D. R., Drachman, D. B., Pestronk, A., Stauch, B. L., & Coyle, J. T. (1990) · Annals of Neurology · doi:10.1002/ana.410280106 · Cited by 636
Donzanti, B. A., & Yamamoto, B. K. (1988) · Life Sciences · doi:10.1016/0024-3205(88)90267-6 · Cited by 353
Self-citationMeldrum, B. S. (1991) · Raven Press eBooks · Cited by 196
Slusher, B. S., Robinson, M. B., Tsai, G. E., Simmons, M. L., Richards, S. S., & Coyle, J. T. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)45359-2 · Cited by 129
Self-citationReductions in acidic amino acids andN-acetylaspartylglutamate in amyotrophic lateral sclerosis CNS
Tsai, G. E., Slusher, B. S., Sim, L., Hedreen, J. C., Rothstein, J. D., Kuncl, R. W., & Coyle, J. T. (1991) · Brain Research · doi:10.1016/0006-8993(91)90560-i · Cited by 107
Self-citation
Cited by
Krystal, J. H., D'Souza, D. C., Mathalon, D., Perry, E., Belger, A., & Hoffman, R. (2003) · Psychopharmacology · doi:10.1007/s00213-003-1582-z · Cited by 530
Neale, J. H., Bzdega, T., & Wroblewska, B. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0750443.x · Cited by 341
Sheikhbahaei, S., Afshar-Oromieh, A., Eiber, M., Solnes, L. B., Javadi, M. S., Ross, A. E., Pienta, K. J., Allaf, M. E., Haberkorn, U., Pomper, M. G., et al. (2017) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-017-3780-7 · Cited by 295
Selective inhibition of NAALADase, which converts NAAG to glutamate, reduces ischemic brain injury
Slusher, B. S., Vornov, J. J., Thomas, A. G., Hurn, P. D., Harukuni, I., Bhardwaj, A., Traystman, R. J., Robinson, M. B., Britton, P., Lu, X.-C. M., et al. (1999) · Nature Medicine · doi:10.1038/70971 · Cited by 295
Self-citationStructure of glutamate carboxypeptidase II, a drug target in neuronal damage and prostate cancer
Mesters, J. R., Barinka, C., Li, W., Tsukamoto, T., Majer, P., Slusher, B. S., Konvalinka, J., & Hilgenfeld, R. (2006) · The EMBO Journal · doi:10.1038/sj.emboj.7600969 · Cited by 284
Self-citationThe Rise of PSMA Ligands for Diagnosis and Therapy of Prostate Cancer
Afshar-Oromieh, A., Babich, J. W., Kratochwil, C., Giesel, F. L., Eisenhut, M., Kopka, K., & Haberkorn, U. (2016) · Journal of Nuclear Medicine · doi:10.2967/jnumed.115.170720 · Cited by 257
Metadata
- Authors
- Jackson, P. F., Cole, D. C., Slusher, B. S., Stetz, S. L., Ross, L. E., Donzanti, B. A., & Trainor, D. A.
- Venue
- Journal of Medicinal Chemistry
- Publisher
- American Chemical Society (ACS)
- Published
- 1996-01-01
- Volume
- 39
- Issue
- 2
- Pages
- 619-622
- ISSN
- 0022-2623 (ISSN-L)
- 1520-4804
- OpenAlex
- W1992868992
- Cited by
- 256
- References
- 6
- FWCI
- 1.75
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.